NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000001741

Registered date:28/02/2009

Phase II study of S-1 combined with irinotecan in patients with advanced colorectal cancer

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedAdvanced colorectal cancer
Date of first enrollment2004/06/01
Target sample size40
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)S-1 combined with irinotecan

Outcome(s)

Primary Outcomethe efficacy, tolerability, and impact on quality-of-life
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximum80years-old
GenderMale and Female
Include criteria
Exclude criteria1)prior chemotherapy received for advanced disease; 2)other severe medical conditions; 3)other active malignancies;

Related Information

Contact

public contact
Name
Address Japan
Telephone
E-mail at1151proc@med.showa-u.ac.jp
Affiliation Showa University School of Medicin Department of Gastroenterological and General Surgery
scientific contact
Name Akira Tsunoda
Address 1-5-8, Hatanodai, Shinagawa, 142-8666, Japan Japan
Telephone
E-mail
Affiliation Showa University School of Medicin Department of Gastroenterological and General Surgery